Platelet nitric oxide signalling in heart failure: Role of oxidative stress

Cardiovascular Research

Volumn 91, Issue 4, 2011, Pages 625-631

  Shah, Ashish ^a   Passacquale, Gabriella ^a   Gkaliagkousi, Eugenia ^a   Ritter, James ^a   Ferro, Albert ^a  

^a Diabetes and Nutritional Sciences Division   (United Kingdom)

Author keywords

Heart failure; Nitric oxide; Oxidative stress; Platelets; Superoxide anion

Indexed keywords

ARGININE; CITRULLINE; COLLAGEN; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SALBUTAMOL; SCAVENGER; SERINE; SUPEROXIDE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE;

ADULT; BLOOD PLATELETS; CELL ADHESION MOLECULES; CYCLIC GMP; FEMALE; HEART FAILURE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 80052015789     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr115     Document Type: Article

References (55)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-225. (Pubitemid 27107582)
2. Ignarro LJ, Buga GM,Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269.
3. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526. (Pubitemid 17085822)
4. Ialenti A, Ianaro A, Moncada S, Di RM. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992;211:177-182.
5. Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 1999;64:673-677. (Pubitemid 30460407)
6. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731-736. (Pubitemid 28096068)
7. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-1058. (Pubitemid 17154788)
8. Dusting GJ, Fennessy P, Yin ZL, Gurevich V. Nitric oxide in atherosclerosis: vascular protector or villain? Clin Exp Pharmacol Physiol Suppl 1998;25:S34-S41. (Pubitemid 28498846)
9. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 2005; 25:1551-1557. (Pubitemid 41098921)
10. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31:51-60. (Pubitemid 29078218)
11. Shah A, Gkaliagkousi E, Ritter JM, Ferro A. Endothelial function and arterial compliance are not impaired in subjects with heart failure of non-ischemic origin. J Card Fail 2010;16:114-120.
12. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998;31:1248-1254. (Pubitemid 28248823)
13. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88:E14-E22.
14. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105: 1656-1662. (Pubitemid 34298608)
15. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-328. (Pubitemid 20292885)
16. Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 1995;57:2049-2055.
17. Ferro A, Queen LR, Priest RM, Xu B, Ritter JM, Poston L et al. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 1999;126:1872-1880. (Pubitemid 29213107)
18. Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A. beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res 2000;87:39-44. (Pubitemid 30456933)
19. Ritter JM, Ferro A, Chowienczyk PJ. Relation between beta-adrenoceptor stimulation and nitric oxide synthesis in vascular control. Eur J Clin Pharmacol 2006;62:109-113.
20. Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996;17:1390-1403. (Pubitemid 26306668)
21. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, Macdonald PS. Increased nitric oxide production in heart failure. Lancet 1994;344:373-374. (Pubitemid 24248210)
22. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1596-1601.
23. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JG. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 1994;344:371-373. (Pubitemid 24248209)
24. Kubo SH, Rector TS, Bank AJ, Raij L, Kraemer MD, Tadros P et al. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol 1994; 74:1133-1136. (Pubitemid 24366514)
25. Elsner D, Muntze A, Kromer EP, Riegger GA. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res 1991;25:438-440.
26. Goubareva I, Gkaliagkousi E, Shah A, Queen L, Ritter J, Ferro A. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. Cardiovasc Res 2007;75:793-802. (Pubitemid 47238740)
27. Wahbi N, Dalton RN, Turner C, Denton M, Abbs I, Swaminathan R. Dimethylarginines in chronic renal failure. J Clin Pathol 2001;54:470-473. (Pubitemid 32531098)
28. Sopi RB, Martin RJ, Haxhiu MA, Dreshaj IA, Yao Q, Jafri A et al. Role of brain-derived neurotrophic factor in hyperoxia-induced enhancement of contractility and impairment of relaxation in lung parenchyma. Am J Physiol Lung Cell Mol Physiol 2008;295: L348-L355.
29. Gambaryan S, Geiger J, Schwarz UR, Butt E, Begonja A, Obergfell A et al. Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood 2004;103:2593-2600. (Pubitemid 38393012)
30. Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, Zamboulis C et al. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J 2009;30:3048-3054.
31. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
32. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100: 350-356. (Pubitemid 27349081)
33. Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res 1999;84:1416-1421. (Pubitemid 29293220)
34. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988; 5:63-69.
35. Bangalore S, Parkar S, Grossman E, Messerli FH. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 2007;100:1254-1262. (Pubitemid 47498283)
36. Krishna CM, Liebmann JE, Kaufman D, DeGraff W, Hahn SM, McMurry T et al. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys 1992;294:98-106.
37. Lopez FA, Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 2001;38:1400-1405. (Pubitemid 34033423)
38. Wu X-B, Brüne B, von Appen F, Ullrich V. Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch Biochem Biophys 1992;294:75-82.
39. Del PD, Menichelli A, De MW, Di Corp ML, Di GS, Finazzi-Agro A. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett 1985;185:142-146.
40. Caccese D, Pratico D, Ghiselli A, Natoli S, Pignatelli P, Sanguigni V et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation-role of arachidonic acid metabolism. Thromb Haemost 2000;83:485-490. (Pubitemid 30148366)
41. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998;91:484-490. (Pubitemid 28053370)
42. Iuliano L, Pedersen JZ, Pratico D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem 1994;221:695-704. (Pubitemid 24128039)
43. De BL, Pignatelli P, Lenti L, Tocci G, Piccioni F, Riondino S et al. Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2-production. Thromb Haemost 2003;90:317-325. (Pubitemid 36992508)
44. Leo R, Pratico D, Iuliano L, Pulcinelli FM, Ghiselli A, Pignatelli P et al. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation 1997;95:885-891. (Pubitemid 27091529)
45. Yamagishi SI, Edelstein D, Du XL, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001;50:1491-1494. (Pubitemid 32500184)
46. Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 1977;59:149-158. (Pubitemid 8018050)
47. Gibson KR, Neilson IL, Barrett F, Winterburn TJ, Sharma S, MacRury SM et al. Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity. J Cardiovasc Pharmacol 2009;54:319-326.
48. Jancinova V, Drabikova K, Nosal R, Danihelova E. Platelet-dependent modulation of polymorphonuclear leukocyte chemiluminescence. Platelets 2000;11:278-285.
49. Buczynski A, Wachowicz B, Kedziora-Kornatowska K, Tkaczewski W, Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993;100:223-228. (Pubitemid 23183721)
50. Pandey NR, Kaur G, Chandra M, Sanwal GG, Misra MK. Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Int J Cardiol 2000;76:33-38.
51. Dhalla AK, Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol 1994;266:H1280-H1285. (Pubitemid 24150753)
52. Seghieri G, Di SP, De Giorgio LA, Anichini R, Alberti L, Franconi F. Relationship between metabolic glycaemic control and platelet content of glutathione and its related enzymes, in insulin-dependent diabetes mellitus. Clin Chim Acta 2000;299: 109-117. (Pubitemid 30438794)
53. Malinin AI, O'Connor CM, Dzhanashvili AI, Sane DC, Serebruany VL. Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?. Am Heart J 2003;145:397-403. (Pubitemid 36390483)
54. Matsuura C, Brunini TM, Carvalho LC, Resende AC, Carvalho JJ, de Castro JP et al. Exercise training in doxorubicin-induced heart failure: effects on the L-arginine-NO pathway and vascular reactivity. J Am Soc Hypertens 2010;4:7-13.
55. Hanssen H, Brunini TM, Conway M, Banning AP, Roberts NB, Mann GE et al. Increased L-arginine transport in human erythrocytes in chronic heart failure. Clin Sci 1998;94:43-48. (Pubitemid 28029807)